Mecasermin rinfabate
- Generic Name
- Mecasermin rinfabate
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 478166-15-3
- Unique Ingredient Identifier
- NZ8M50KKRG
- Background
Mecasermin rinfabate is approved for severe primary insulin-like growth factor (IGF) deficiency or in patients with GH gene deletion who have developed antibodies to growth hormone (GH). Mecasermin rinfabate is similar to Mecasermin in that both drugs contain recombinant DNA origin insulin-like growth factor 1 (IGF-1). Mecasermin rinfabate however, is alread...
- Indication
Mecasermin rinfabate was approved for treatment of severe primary insulin-like growth factor (IGF) deficiency or in patients with GH gene deletion who have developed antibodies to growth hormone (GH).
Severe primary IGF-1 deficiency is defined by:
A) height standard deviation (SD) score less than or equal to 3 SD below normal
...
- Associated Conditions
- Growth Hormone Gene Deletion, Primary Insulin-like Growth Factor-1 Deficiency
- Associated Therapies
- -
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.